Lutz Wollin

Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

B. Ryffel, L. Wollin, V. Quesniaux, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Alexander Pautsch, Gisela Schnapp, A. Pautsch, 2015, European Respiratory Journal.